| |
| |
|
| Insider
Information: |
Fitzgerald Edward M |
| Relationship: |
Executive VP |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
320,367 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
320,367 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
Executive VP |
2016-03-21 |
320,367 |
2011-03-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• – – |
2012-03-23 |
4 |
AS |
$15.41 |
$199,239 |
D/D |
(12,933) |
160,080 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• – – |
2012-04-17 |
4 |
AS |
$15.00 |
$600,000 |
D/D |
(40,000) |
169,548 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2012-07-02 |
4 |
AS |
$17.64 |
$440,950 |
D/D |
(25,000) |
204,767 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2012-10-01 |
4 |
AS |
$24.17 |
$604,188 |
D/D |
(25,000) |
179,767 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2013-01-02 |
4 |
AS |
$20.08 |
$501,890 |
D/D |
(25,000) |
166,543 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2014-09-02 |
4 |
AS |
$6.22 |
$310,835 |
D/D |
(50,000) |
280,960 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-02-02 |
4 |
AS |
$6.33 |
$92,849 |
D/D |
(14,667) |
295,627 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-03-20 |
4 |
AS |
$8.84 |
$47,908 |
D/D |
(5,417) |
301,043 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-03-23 |
4 |
AS |
$8.55 |
$35,630 |
D/D |
(4,167) |
305,209 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-05-01 |
4 |
AS |
$8.80 |
$528,000 |
D/D |
(60,000) |
305,852 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-07-16 |
4 |
AS |
$8.54 |
$59,793 |
D/D |
(7,000) |
313,339 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-08-28 |
4 |
AS |
$10.00 |
$328,580 |
D/D |
(32,858) |
280,481 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2015-09-28 |
4 |
AS |
$6.46 |
$56,551 |
D/D |
(8,750) |
289,231 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2016-02-01 |
4 |
AS |
$4.81 |
$70,515 |
D/D |
(14,667) |
305,326 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2016-03-03 |
4 |
AS |
$6.12 |
$58,866 |
D/D |
(9,625) |
314,951 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP |
• – – |
2016-03-21 |
4 |
AS |
$6.47 |
$35,037 |
D/D |
(5,417) |
320,367 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• – – |
2011-04-11 |
4 |
D |
$7.76 |
$78,120 |
D/D |
(10,067) |
93,880 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2012-12-18 |
4 |
D |
$20.18 |
$164,306 |
D/D |
(8,142) |
191,357 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2013-03-20 |
4 |
D |
$20.45 |
$55,665 |
D/D |
(2,722) |
172,155 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2013-07-15 |
4 |
D |
$20.98 |
$277,565 |
D/D |
(13,230) |
214,585 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2013-08-15 |
4 |
D |
$18.11 |
$350,284 |
D/D |
(19,342) |
228,243 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$28,133 |
D/D |
(3,435) |
255,940 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2014-03-20 |
4 |
D |
$8.13 |
$22,089 |
D/D |
(2,717) |
261,556 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2014-04-01 |
4 |
D |
$8.52 |
$36,108 |
D/D |
(4,238) |
270,928 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Executive VP, CFO |
• • – |
2014-07-15 |
4 |
D |
$5.57 |
$25,421 |
D/D |
(4,564) |
280,960 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
